Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | MK-4716 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on MK-4716 (Jan 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| MK-4716 | MK4716|MK 4716 | Limited information is currently available on MK-4716 (Jan 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07247110 | Phase I | MK-4716 MK-4716 + Pembrolizumab Cetuximab + MK-4716 | A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001) | Recruiting | USA | ISR | ESP | 0 |